Vo
lu
m
e
5,
M
ay
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
PERIODONTAL DISEASE: MECHANISMS OF PATHOGENESIS – A
LITERATURE REVIEW
Jumayev Miraziz Makhmud ugli
Bukhara state medical institute
Abstract.
Periodontal disease is a chronic inflammatory condition affecting the supporting
structures of the teeth, including the gingiva, periodontal ligament, cementum, and alveolar
bone. It is primarily caused by the accumulation of microbial biofilms on tooth surfaces,
leading to host immune responses that can result in progressive tissue destruction. This
literature review aims to summarize current knowledge on the etiology and pathogenesis of
periodontal disease, highlighting the role of microbial factors, host immune response,
genetic predisposition, and environmental influences such as smoking and stress.
Understanding the multifactorial nature of periodontal disease is essential for developing
targeted preventive and therapeutic strategies.
Keywords
: periodontal disease, pathogenesis, inflammation, oral microbiota, host immune
response, risk factors, biofilm, gingival inflammation
Introduction
. Periodontal disease, encompassing a spectrum of inflammatory conditions
affecting the supporting structures of the teeth, stands as a significant global public health
concern. Characterized by the progressive destruction of the periodontal ligament and
alveolar bone, it often culminates in tooth loss if left untreated. The etiology of periodontal
disease is multifactorial, involving complex interactions between pathogenic
microorganisms in dental biofilms and the host's immune response [1,5].
Epidemiological data underscore the extensive prevalence of periodontal disease worldwide.
According to the Global Burden of Disease Study 2021, over 1 billion individuals were
affected by severe periodontitis, with an age-standardized prevalence of 12.5% . Notably,
South Asia exhibited the highest prevalence rate at 17.6%. Projections indicate a substantial
increase in the burden of severe periodontitis, with estimates suggesting that by 2050, more
than 1.5 billion people will be affected, marking a 44.3% rise from 2021 [11].
The pathogenesis of periodontal disease is intricately linked to the host's immune-
inflammatory response to microbial colonization. Initial bacterial accumulation triggers an
innate immune response, characterized by the recruitment of neutrophils and the release of
pro-inflammatory cytokines such as interleukin-1β (IL-1β) and tumor necrosis factor-alpha
(TNF-α). These mediators not only orchestrate the inflammatory response but also stimulate
the production of matrix metalloproteinases (MMPs), enzymes responsible for the
degradation of extracellular matrix components, leading to connective tissue breakdown
[12].
Furthermore,
the
receptor
activator
of
nuclear
factor
kappa-Β
ligand
(RANKL)/osteoprotegerin (OPG) axis plays a pivotal role in alveolar bone resorption
associated with periodontitis [4,12]. An imbalance favoring RANKL promotes osteoclast
differentiation and activation, resulting in bone loss. Additionally, emerging evidence
Vo
lu
m
e
5,
M
ay
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
highlights the contribution of dysbiosis—a disruption in the composition of the oral
microbiota—to the chronicity and progression of periodontal disease [14].
Given the complex interplay of microbial, immunological, and environmental factors in
periodontal disease pathogenesis, a comprehensive understanding of these mechanisms is
essential for the development of effective preventive and therapeutic strategies. This
literature review aims to elucidate the current knowledge on the etiopathogenic mechanisms
underlying periodontal disease, with a focus on microbial interactions, host immune
responses, and the molecular pathways involved in tissue destruction[2, 8].
Periodontal disease, a chronic inflammatory condition affecting the supporting structures of
the teeth, has been extensively studied due to its high prevalence and association with
systemic health issues. Globally, periodontal diseases affect up to 90% of the population,
making them the most common oral diseases [10,14]. In 2021, over 1 billion individuals
were affected by severe periodontitis, with an age-standardized prevalence of 12.5% [9,11].
The pathogenesis of periodontal disease involves a complex interplay between microbial
biofilms and the host's immune response. The commensal oral bacteria initiate the disease
through dysbiosis, leading to an inflammatory response characterized by the release of pro-
inflammatory cytokines such as interleukin-1β (IL-1β) and tumor necrosis factor-alpha
(TNF-α). These mediators stimulate the production of matrix metalloproteinases (MMPs),
enzymes responsible for the degradation of extracellular matrix components, resulting in
connective tissue breakdown [14] .
Moreover, the receptor activator of nuclear factor kappa-Β ligand (RANKL)/osteoprotegerin
(OPG) axis plays a pivotal role in alveolar bone resorption associated with periodontitis. An
imbalance favoring RANKL promotes osteoclast differentiation and activation, leading to
bone loss.
Several risk factors contribute to the development and progression of periodontal disease.
Smoking is a significant modifiable risk factor, with smokers being three times more likely
to develop severe periodontitis compared to non-smokers[15 ]. Diabetes mellitus is another
critical risk factor, as it exacerbates the inflammatory response and impairs healing, leading
to increased periodontal destruction. Stress, poor oral hygiene, and certain medications also
play roles in disease progression.
The association between periodontal disease and systemic conditions has been well-
documented. Periodontitis has been linked to cardiovascular diseases, with studies indicating
a 19% increased risk of cardiovascular disease in individuals with periodontal disease, and
this risk increases to 44% among those aged 65 years and over. Additionally, periodontitis is
associated with adverse pregnancy outcomes, respiratory diseases, rheumatoid arthritis, and
certain cancers [15].
Methodology
.This literature review was conducted to synthesize current knowledge on the
pathogenesis of periodontal disease. A comprehensive search of electronic databases,
including PubMed, Scopus, and Web of Science, was performed to identify relevant studies
published up to April 2025. The search strategy utilized keywords such as "periodontal
Vo
lu
m
e
5,
M
ay
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
disease," "pathogenesis," "inflammation," "oral microbiota," "host immune response," and
"risk factors."
Inclusion criteria encompassed peer-reviewed articles, systematic reviews, meta-analyses,
and clinical studies that focused on the mechanisms of periodontal disease development and
progression. Studies were selected based on their relevance, methodological rigor, and
contribution to understanding the multifactorial nature of periodontal disease.
Data extraction involved summarizing findings related to microbial factors, host immune
responses, genetic predispositions, and environmental influences contributing to periodontal
disease. Statistical data on prevalence, incidence, and associations with systemic conditions
were also collated to provide a comprehensive overview.
The review aimed to integrate current evidence to elucidate the complex interactions
underlying periodontal disease pathogenesis, thereby informing future research directions
and potential therapeutic strategies.
Results
Global Prevalence and Trends
. Periodontal disease remains a significant global health
concern, with its prevalence and burden increasing over the past decades. According to the
Global Burden of Disease Study 2021, over 1 billion individuals were affected by severe
periodontitis, with an age-standardized prevalence of 12.5%. South Asia exhibited the
highest prevalence rate at 17.6%. Projections indicate that by 2050, more than 1.5 billion
people will be affected, marking a 44.3% rise from 2021[6,7].
The burden of severe periodontitis, measured in Years Lived with Disability (YLDs), was
6.90 million globally in 2021. By 2050, this is expected to increase to 10.06 million YLDs,
representing a 43.3% rise. Severe periodontitis is projected to become the 30th most
impactful Level 4 disease/condition globally by 2050, moving up one position from its 2021
ranking [11].
Demographic and Risk Factor Associations
. The prevalence of periodontal disease
increases with age. In the United States, 42.2% of adults aged 30 years or older had
periodontitis, with 7.8% having severe periodontitis. Among individuals aged 65 years and
older, the prevalence rises to 79.3% [16].
Smoking is a significant modifiable risk factor, accounting for approximately 42% of
periodontitis cases. Diabetes mellitus increases the risk of periodontitis approximately three-
fold compared to non-diabetic individuals. The combined presence of smoking and diabetes
significantly heightens the risk for severe periodontal disease [16].
Immunopathogenic Mechanisms
. The pathogenesis of periodontal disease involves a
complex interplay between microbial biofilms and the host's immune response. The initial
bacterial accumulation triggers an innate immune response, characterized by the recruitment
of neutrophils and the release of pro-inflammatory cytokines such as interleukin-1β (IL-1β)
and tumor necrosis factor-alpha (TNF-α). These mediators stimulate the production of
Vo
lu
m
e
5,
M
ay
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
matrix metalloproteinases (MMPs), enzymes responsible for the degradation of extracellular
matrix components, leading to connective tissue breakdown.
The receptor activator of nuclear factor kappa-Β ligand (RANKL)/osteoprotegerin (OPG)
axis plays a pivotal role in alveolar bone resorption associated with periodontitis. An
imbalance favoring RANKL promotes osteoclast differentiation and activation, resulting in
bone loss.
Emerging evidence highlights the contribution of inflammasomes, particularly the NLRP3
inflammasome, in periodontal inflammation. Excessive activation of inflammasomes leads
to the release of pro-inflammatory cytokines IL-1β and IL-18, contributing to tissue damage.
Patients with periodontal pathologies present elevated levels of certain inflammasomes in
saliva, proportional to the severity of the disease [17].
Discussion
. Periodontal disease remains a significant global health concern, with its
prevalence and burden increasing over the past decades. According to the Global Burden of
Disease Study 2021, over 1 billion individuals were affected by severe periodontitis, with an
age-standardized prevalence of 12.5%. South Asia exhibited the highest prevalence rate at
17.6%. Projections indicate that by 2050, more than 1.5 billion people will be affected,
marking a 44.3% rise from 2021.
The pathogenesis of periodontal disease involves a complex interplay between microbial
biofilms and the host's immune response. The initial bacterial accumulation triggers an
innate immune response, characterized by the recruitment of neutrophils and the release of
pro-inflammatory cytokines such as interleukin-1β (IL-1β) and tumor necrosis factor-alpha
(TNF-α). These mediators stimulate the production of matrix metalloproteinases (MMPs),
enzymes responsible for the degradation of extracellular matrix components, leading to
connective tissue breakdown.
The receptor activator of nuclear factor kappa-Β ligand (RANKL)/osteoprotegerin (OPG)
axis plays a pivotal role in alveolar bone resorption associated with periodontitis. An
imbalance favoring RANKL promotes osteoclast differentiation and activation, resulting in
bone loss.
Several risk factors contribute to the development and progression of periodontal disease.
Smoking is a significant modifiable risk factor, accounting for approximately 42% of
periodontitis cases. Diabetes mellitus increases the risk of periodontitis approximately three-
fold compared to non-diabetic individuals. The combined presence of smoking and diabetes
significantly heightens the risk for severe periodontal disease [17].
The association between periodontal disease and systemic conditions has been well-
documented. Periodontitis has been linked to cardiovascular diseases, with studies indicating
a 19% increased risk of cardiovascular disease in individuals with periodontal disease, and
this risk increases to 44% among those aged 65 years and over. Additionally, periodontitis is
associated with adverse pregnancy outcomes, respiratory diseases, rheumatoid arthritis, and
certain cancers.
Vo
lu
m
e
5,
M
ay
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
Emerging evidence highlights the contribution of inflammasomes, particularly the NLRP3
inflammasome, in periodontal inflammation. Excessive activation of inflammasomes leads
to the release of pro-inflammatory cytokines IL-1β and IL-18, contributing to tissue damage.
Patients with periodontal pathologies present elevated levels of certain inflammasomes in
saliva, proportional to the severity of the disease.
Given the complex interplay of
microbial, immunological, and environmental factors in periodontal disease pathogenesis, a
comprehensive understanding of these mechanisms is essential for the development of
effective preventive and therapeutic strategies. This literature review aims to elucidate the
current knowledge on the etiopathogenic mechanisms underlying periodontal disease, with a
focus on microbial interactions, host immune responses, and the molecular pathways
involved in tissue destruction.
Conclusion
. Periodontal disease is a multifactorial inflammatory condition that results from
the complex interplay between microbial dysbiosis, host immune responses, and
environmental risk factors. As the most prevalent chronic oral disease globally, affecting
over one billion individuals and projected to rise by more than 44% by 2050, its public
health implications are substantial.
The pathogenesis involves an orchestrated immune-inflammatory cascade triggered by
pathogenic biofilms. Central mediators such as interleukin-1β, tumor necrosis factor-alpha,
matrix metalloproteinases, and the RANKL/OPG axis contribute significantly to connective
tissue degradation and alveolar bone resorption. Emerging findings on the role of
inflammasomes and genetic susceptibility are expanding our understanding of periodontal
destruction at the molecular level.
Furthermore, the strong associations between periodontitis and systemic conditions—
including cardiovascular disease, diabetes mellitus, and adverse pregnancy outcomes—
underscore the importance of periodontal health in systemic disease prevention. Risk factors
such as smoking, aging, and metabolic disorders further amplify disease progression and
severity.
Given the increasing global burden and systemic relevance of periodontitis, early diagnosis,
targeted prevention strategies, and personalized treatment protocols are essential. Future
research should prioritize longitudinal and mechanistic studies to refine molecular targets
and develop novel therapeutic interventions aimed at modulating both microbial
communities and host responses.
References
1.
Albandar, J. M., & Rams, T. E. (2002). Global epidemiology of periodontal diseases:
An overview.
Periodontology 2000, 29
(1), 7–10. https://doi.org/10.1034/j.1600-
0757.2002.290102.x
2.
Eke, P. I., Thornton-Evans, G. O., Wei, L., Borgnakke, W. S., Dye, B. A., & Genco,
R. J. (2018). Periodontitis in US adults: National Health and Nutrition Examination Survey
2009–2014.
Journal of the American Dental Association, 149
(7), 576–588.e6.
https://doi.org/10.1016/j.adaj.2018.04.023
Vo
lu
m
e
5,
M
ay
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
3.
Hajishengallis, G. (2015). Periodontitis: From microbial immune subversion to
systemic
inflammation.
Nature
Reviews
Immunology,
15
(1),
30–44.
https://doi.org/10.1038/nri3785
4.
Kinane, D. F., Stathopoulou, P. G., & Papapanou, P. N. (2017). Periodontal diseases.
Nature Reviews Disease Primers, 3
(1), 17038. https://doi.org/10.1038/nrdp.2017.38
5.
Kwon, T., Lamster, I. B., & Levin, L. (2021). Current concepts in the etiology and
pathogenesis of periodontitis.
Journal of the Korean Association of Oral and Maxillofacial
Surgeons, 47
(2), 90–102. https://doi.org/10.5125/jkaoms.2021.47.2.90
6.
Mei, Y., Tang, Z., Wu, C., Tian, X., Wang, Z., & Zhang, L. (2024). Global, regional,
and national burden and trends of severe periodontitis, 1990 to 2021, with projections to
2050: A systematic analysis.
Journal of Clinical Periodontology
. Advance online
publication. https://doi.org/10.1111/jcpe.13780
7.
Preshaw, P. M., Alba, A. L., Herrera, D., Jepsen, S., Konstantinidis, A., Makrilakis,
K., & Taylor, R. (2012). Periodontitis and diabetes: A two-way relationship.
Diabetologia,
55
(1), 21–31. https://doi.org/10.1007/s00125-011-2342-y
8.
Slots, J. (2017). Periodontitis: Facts, fallacies and the future.
Periodontology 2000,
75
(1), 7–23. https://doi.org/10.1111/prd.12219
9.
Van Dyke, T. E., & Kornman, K. S. (2008). Inflammation and factors that may
regulate inflammatory response.
Journal of Periodontology, 79
(8S), 1503–1507.
https://doi.org/10.1902/jop.2008.080233
10.
Zhang, S., Crivello, A., Offenbacher, S., Morelli, T., Paquette, D. W., Barros, S. P.,
& Divaris, K. (2021). Inflammasome gene polymorphisms and salivary biomarkers in
periodontitis.
Journal
of
Periodontology,
92
(9),
1337–1348.
https://doi.org/10.1002/JPER.20-0550
11.
Nascimento, G. G., Alves-Costa, S., & Romandini, M. (2024). Burden of severe
periodontitis and edentulism in 2021, with projections up to 2050: The Global Burden of
Disease
2021
study.
Journal
of
periodontal
research
,
59
(5),
823–867.
https://doi.org/10.1111/jre.13337
12.
Qasim, S. S. B., Al-Otaibi, D., Al-Jasser, R., Gul, S. S., & Zafar, M. S. (2020). An
Evidence-Based Update on the Molecular Mechanisms Underlying Periodontal
Diseases.
International
journal
of
molecular
sciences
,
21
(11),
3829.
https://doi.org/10.3390/ijms21113829
13.
Hajishengallis, G., Chavakis, T., & Lambris, J. D. (2020). Current understanding of
periodontal disease pathogenesis and targets for host-modulation therapy.
Periodontology
2000
,
84
(1), 14–34.
https://doi.org/10.1111/prd.12331
14.
Gasner, N. S., & Schure, R. S. (2023, April 10).
Periodontal disease
. In StatPearls.
StatPearls Publishing.
https://www.ncbi.nlm.nih.gov/books/NBK554590
15.
Nazir M. A. (2017). Prevalence of periodontal disease, its association with systemic
diseases and prevention.
International journal of health sciences
,
11
(2), 72–80.
16.
NewMouth.
(2024, March 15).
Statistics and trends in periodontal disease
.
https://www.newmouth.com/oral-health/periodontal-disease-statistics/
17.
López-Valverde, N., Quispe-López, N., & Blanco Rueda, J. A. (2024). Inflammation
and immune response in the development of periodontal disease: a narrative
review.
Frontiers
in
cellular
and
infection
microbiology
,
14
,
1493818.
https://doi.org/10.3389/fcimb.2024.1493818
